Navigation Links
Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
Date:10/31/2013

LAVAL, Quebec, Oct. 31, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces third quarter financial results for 2013.

  • Total Revenue $1.54 billion; an increase of 74% over the prior year
  • 4% organic growth (same store sales) for the Developed Markets segment, excluding the impact from Zovirax franchise, Retin-A Micro and BenzaClin generic products
  • 14% organic growth (same store sales) for the Emerging Markets segment
  • 10% organic growth for Bausch + Lomb since close versus prior year
  • GAAP EPS loss of $2.92; Cash EPS $1.43, an increase of 24% over the prior year; adjusting for pre-closing Bausch + Lomb financing costs of $0.09, Cash EPS would have been $1.51, an increase of 31% over prior year
  • GAAP Operating Cash Flow $202 million; Adjusted Operating Cash Flow $408 million; an increase of 69% over the prior year
  • Bausch + Lomb integration on track and Valeant expects to realize more than $850 million in synergies
  • 2013 Guidance for Cash EPS updated to $6.11 to $6.16
  • "Despite an unexpected early launch of a generic Retin-A Micro, significant headwinds this quarter from foreign exchange movements, and the demands of a major integration, we managed to beat expectations and position Valeant for a terrific fourth quarter and a strong 2014," stated J. Michael Pearson, chairman and chief executive officer.  "I thank our team, both at Valeant and our new colleagues from Bausch + Lomb, for their commitment, diligence, and focus on execution.  I am confident that our strategic focus on diversification, durable assets, key geographies, and low risk R&D will continue to benefit our shareholders as we look forward to continuing our track record of outperformance." 

    Valeant Third Quarter Financial ResultsValeant's total revenues were $1.54 billio
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related medicine technology :

    1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
    2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
    3. Valeant Pharmaceuticals To Host Investor Day
    4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
    5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
    6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
    7. Valeant Pharmaceuticals Announces Management Change
    8. Valeant Pharmaceuticals To Syndicate Incremental Loans
    9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
    10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
    11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/17/2014)... TAMPA, Fla. , Sept. 17, 2014   ... announced today that Business Insurance magazine has ... Insurance" distinction for the third year in a row. ... joint effort of Business Insurance  and the Best ... evaluation, is open to all publicly or privately-held insurance ...
    (Date:9/17/2014)... ANGELES and LEIPZIG, Germany ... today announced that it has entered into an ... the development of antibody-based imaging agents to image ... "Our collaboration with Novotectid expands ImaginAb,s capability to precisely ... immune-oncology and autoimmune disease areas. The ability to ...
    (Date:9/17/2014)... PALO ALTO, Calif. , Sept. 17, 2014 /PRNewswire/ ... of the Company,s Phase 2 clinical program of NP001 ... Lou Gehrig,s disease) are being highlighted today ... of the ALS Research Group , being held in ... According to a  post hoc  analysis, administration of a ...
    Breaking Medicine Technology:myMatrixx Honored with "Best Places to Work in Insurance" Award 2ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3
    ... Reportlinker.com announces that a new market research report ... Drug Delivery in Central Nervous System Diseases - ... The delivery of drugs ... in the treatment of neurological disorders. Drugs may ...
    ... Robbins & Myers, Inc. (NYSE: ... its Romaco businesses to a group of funds led ... investment firm.  Total consideration was approximately euro 65 million ... and euro 4 million of assumed liabilities and is ...
    Cached Medicine Technology:Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 2Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 3Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 4
    (Date:9/17/2014)... Vegas, NV (PRWEB) September 17, 2014 ... Dr. Dan Ritchie and Dr. Cody Sipe that is helping ... of life and longevity has caught the attention of Shane ... most people in their 50s, 60s, or even 70s what ... of life on a day-to-day basis, they would probably answer ...
    (Date:9/17/2014)... these sound like the ideas of a science ... of an exciting new approach to imaging local ... metastatic prostate cancer, scientists at Virginia Commonwealth University ... and Johns Hopkins Medical Institutions have provided proof-of-principle ... revolutionize doctors, ability to see tumors that have ...
    (Date:9/17/2014)... Tidewater Physical Therapy and ... for football players and their parents at its Newport ... open at 6:30 p.m. for athletes and parents to ... and physical therapists. The workshop will start at 7 ... News Tidewater Performance Center, which features sports performance and ...
    (Date:9/17/2014)... University] As Congress adjourns this month for the ... step over on their way out the chamber door ... Medicare Provider Payment Modernization Act of 2014. In a ... Dr. Eli Adashi recounts what he and other advocates ... The perennial trouble with how Medicare pays doctors will ...
    (Date:9/17/2014)... Toledo, Ohio (PRWEB) September 17, 2014 ... hearing for today, September 17, 2014, to consider: , ... Testosterone Replacement Therapy (TRT), and, 2. ... of TRT. , With the TRT litigation ongoing, an ... FDA on the dangers of testosterone replacement therapy. Among ...
    Breaking Medicine News(10 mins):Health News:Functional Fitness Solution: Review Exposes Dr. Dan Ritchie and Dr. Cody Sipe’s Guide to Everyday Fitness for Longevity 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2
    ... July 1 AlphaMed Press, co-publisher of the journal ... stem cells and regenerative medicine, has promoted Miodrag Stojkovic ... is Deputy Director of the Prince Felipe Research Centre ... Spain. He led the team that first announced derivation ...
    ... ... two winners of their 2009 North American Grant Program. Exiqon had recently announced ... non-profit institutions across North America, engaged in microRNA research. , ... (PRWEB) July 1, 2009 -- Exiqon A/S ...
    ... ... the past 30 years, The Free Choice Foundation is a newly established grassroots organization ... with regards to healthcare. , ... Tokyo, Japan (PRWEB) July 1, 2009 -- Based on the spirit of ...
    ... Also recommends dosing limits for OTC products that contain ... liver damage. , TUESDAY, June 30 (HealthDay News) ... combine acetaminophen with an opiate narcotic, should be banned, ... like Tylenol or Excedrin, should be lowered, a U.S. ...
    ... Disease , , WASHINGTON, June 30 Today Lung ... Cancer illustrating again the devastating toll caused by lung cancer. ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ) ... analyzes the most recent available data from the National Institutes of ...
    ... Andrew Ordon, co-host of the syndicated talk show The ... a non-invasive skin contouring procedure, at his state-of-the-art surgical facilities ... is the perfect option for someone who wants to look ... explains Ordon. "There is little to no downtime with this ...
    Cached Medicine News:Health News:STEM CELLS Promotes Miodrag Stojkovic to Editor 2Health News:Exiqon Announces 2009 North American Grant Award Winners 2Health News:Exiqon Announces 2009 North American Grant Award Winners 3Health News:Newly Launched Free Choice Foundation Attempts Rescue of Japan's Private Heath Care Network 2Health News:Newly Launched Free Choice Foundation Attempts Rescue of Japan's Private Heath Care Network 3Health News:FDA Panel Urges Ban on Vicodin, Percocet 2Health News:FDA Panel Urges Ban on Vicodin, Percocet 3Health News:FDA Panel Urges Ban on Vicodin, Percocet 4Health News:Lung Cancer Alliance Releases Updated 2009 Facts About Lung Cancer 2
    ... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
    50L...
    ... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
    ... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
    Medicine Products: